Cargando…

Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist

Heartburn and acid regurgitation are the cardinal symptoms of gastroesophageal reflux and occur commonly in the Canadian population. Multiple non-prescription treatment options are available for managing these symptoms, including antacids, alginates, histamine-H2 receptor antagonists (H2RAs), and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, David, Nakhla, Nardine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184381/
https://www.ncbi.nlm.nih.gov/pubmed/28042359
http://dx.doi.org/10.18549/PharmPract.2016.04.868
_version_ 1782486238677172224
author Armstrong, David
Nakhla, Nardine
author_facet Armstrong, David
Nakhla, Nardine
author_sort Armstrong, David
collection PubMed
description Heartburn and acid regurgitation are the cardinal symptoms of gastroesophageal reflux and occur commonly in the Canadian population. Multiple non-prescription treatment options are available for managing these symptoms, including antacids, alginates, histamine-H2 receptor antagonists (H2RAs), and proton-pump inhibitors (PPIs). As a result, pharmacists are ideally positioned to recommend appropriate treatment options based upon an individual’s needs and presenting symptoms, prior treatment response, comorbid medical conditions, and other relevant factors. Individuals who experience mild heartburn and/or have symptoms that occur predictably in response to known precipitating factors can manage their symptoms by avoiding known triggers and using on-demand antacids and/or alginates or lower-dose non-prescription H2RAs (e.g. ranitidine 150 mg). For those with moderate symptoms, lifestyle changes, in conjunction with higher-dose non-prescription H2RAs, may be effective. However, for individuals with moderate-to-severe symptoms that occur frequently (i.e. ≥2 days/week), the non-prescription (Schedule II) PPI omeprazole 20 mg should be considered. The pharmacist can provide important support by inquiring about the frequency and severity of symptoms, identifying an appropriate treatment option, and recognizing other potential causes of symptoms, as well as alarm features and atypical symptoms that would necessitate referral to a physician. After recommending an appropriate treatment, the pharmacist can provide instructions for its correct use. Additionally, the pharmacist should inquire about recurrences, respond to questions about adverse events, provide monitoring parameters, and counsel on when referral to a physician is warranted. Pharmacists are an essential resource for individuals experiencing heartburn; they play a crucial role in helping individuals make informed self-care decisions and educating them to ensure that therapy is used in an optimal, safe, and effective manner.
format Online
Article
Text
id pubmed-5184381
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-51843812016-12-30 Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist Armstrong, David Nakhla, Nardine Pharm Pract (Granada) Review Heartburn and acid regurgitation are the cardinal symptoms of gastroesophageal reflux and occur commonly in the Canadian population. Multiple non-prescription treatment options are available for managing these symptoms, including antacids, alginates, histamine-H2 receptor antagonists (H2RAs), and proton-pump inhibitors (PPIs). As a result, pharmacists are ideally positioned to recommend appropriate treatment options based upon an individual’s needs and presenting symptoms, prior treatment response, comorbid medical conditions, and other relevant factors. Individuals who experience mild heartburn and/or have symptoms that occur predictably in response to known precipitating factors can manage their symptoms by avoiding known triggers and using on-demand antacids and/or alginates or lower-dose non-prescription H2RAs (e.g. ranitidine 150 mg). For those with moderate symptoms, lifestyle changes, in conjunction with higher-dose non-prescription H2RAs, may be effective. However, for individuals with moderate-to-severe symptoms that occur frequently (i.e. ≥2 days/week), the non-prescription (Schedule II) PPI omeprazole 20 mg should be considered. The pharmacist can provide important support by inquiring about the frequency and severity of symptoms, identifying an appropriate treatment option, and recognizing other potential causes of symptoms, as well as alarm features and atypical symptoms that would necessitate referral to a physician. After recommending an appropriate treatment, the pharmacist can provide instructions for its correct use. Additionally, the pharmacist should inquire about recurrences, respond to questions about adverse events, provide monitoring parameters, and counsel on when referral to a physician is warranted. Pharmacists are an essential resource for individuals experiencing heartburn; they play a crucial role in helping individuals make informed self-care decisions and educating them to ensure that therapy is used in an optimal, safe, and effective manner. Centro de Investigaciones y Publicaciones Farmaceuticas 2016 2016-12-15 /pmc/articles/PMC5184381/ /pubmed/28042359 http://dx.doi.org/10.18549/PharmPract.2016.04.868 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Armstrong, David
Nakhla, Nardine
Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
title Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
title_full Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
title_fullStr Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
title_full_unstemmed Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
title_short Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist
title_sort non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the canadian pharmacist
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184381/
https://www.ncbi.nlm.nih.gov/pubmed/28042359
http://dx.doi.org/10.18549/PharmPract.2016.04.868
work_keys_str_mv AT armstrongdavid nonprescriptionprotonpumpinhibitorsforselftreatingfrequentheartburntheroleofthecanadianpharmacist
AT nakhlanardine nonprescriptionprotonpumpinhibitorsforselftreatingfrequentheartburntheroleofthecanadianpharmacist